Maria da Graça Morais Martin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria da Graça Morais Martin has a total of 149 co-authors. Here are the top co-authors by number of shared publications:
- Edson Amaro
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
6 shared publications Claudia da Costa Leite
Departamento de Radiologia e Oncologia, Faculdade de Medicina, Universidade de São Paulo, Sao Paulo, Brazil
5 shared publications- Ricardo Nitrini
Universidade de São Paulo, Brazil
5 shared publications - Adriana Bastos Conforto
Hospital Israelita Albert Einstein, São Paulo, Brazil
4 shared publications André Fujita
Institute of Medical Sciences, University of Tokyo, Japan
4 shared publicationsGiovanni Guido Cerri
Universidade de São Paulo, Brazil
4 shared publications
Latest Publications
- Open Access
- 26 September 2025
- Published by Springer Nature in Neuroradiology
- Vol. 67 (11) , 3121-3136
Structured assessment of brain MRI in Covid-19–related neurological disease: an international multicentre study
Purpose: Neuroradiological findings associated with neurological presentations in acute SARS-CoV-2 infection are very heterogeneous. We aimed to develop a standardized framework for describing MR neuroimaging patterns in Covid-19, to test this in an international multicentre study and to determine the prevalence of observed MRI patterns and their association with clinical presentation and outcome. Methods: An international expert consortium developed a framework for assessment of brain MRI patterns in Covid-19 based on published literature and professional experience. We performed a retrospective analysis of the proposed framework, involving brain MRI scans from 458 Covid-19 patients with neurological symptoms, including data from 1 February to 31 May 2020. Two readers at 25 centres across five countries assessed the local MRI studies regarding the presence of one or more predefined MRI patterns. Imaging and clinical data were analysed using Bayesian statistics. Results: Of 458 patients, 58.5% had an abnormal MRI. Overall, 94% of all imaging pathologies seen were captured by our proposed classification. Ischemic strokes were the most frequent pattern overall (25.6%), followed by microhaemorrhages (15.9%). Ischemic infarct patterns were more frequent in non-ICU patients, while the haemorrhagic patterns were more frequent in ICU patients. White matter lesions (10.9%) were more frequent than grey matter lesions (8.1%), and leptomeningeal contrast enhancement was present in 8.3% of patients. Patient outcome was not associated with any MRI patterns. Conclusion: Our proposed classification of specific MRI patterns in Covid-19, covered 94% of observed abnormalities, while patient outcome, death or home discharge, was not associated with any MRI patterns.
- 26 September 2025
- Published by Springer Nature in Neuroradiology
- Vol. 67 (11) , 3121-3136
Open AccessStructured assessment of brain MRI in Covid-19–related neurological disease: an international multicentre study
Purpose: Neuroradiological findings associated with neurological presentations in acute SARS-CoV-2 infection are very heterogeneous. We aimed to develop a standardized framework for describing MR neuroimaging patterns in Covid-19, to test this in an international multicentre study and to determine the prevalence of observed MRI patterns and their association with clinical presentation and outcome. Methods: An international expert consortium developed a framework for assessment of brain MRI patterns in Covid-19 based on published literature and professional experience. We performed a retrospective analysis of the proposed framework, involving brain MRI scans from 458 Covid-19 patients with neurological symptoms, including data from 1 February to 31 May 2020. Two readers at 25 centres across five countries assessed the local MRI studies regarding the presence of one or more predefined MRI patterns. Imaging and clinical data were analysed using Bayesian statistics. Results: Of 458 patients, 58.5% had an abnormal MRI. Overall, 94% of all imaging pathologies seen were captured by our proposed classification. Ischemic strokes were the most frequent pattern overall (25.6%), followed by microhaemorrhages (15.9%). Ischemic infarct patterns were more frequent in non-ICU patients, while the haemorrhagic patterns were more frequent in ICU patients. White matter lesions (10.9%) were more frequent than grey matter lesions (8.1%), and leptomeningeal contrast enhancement was present in 8.3% of patients. Patient outcome was not associated with any MRI patterns. Conclusion: Our proposed classification of specific MRI patterns in Covid-19, covered 94% of observed abnormalities, while patient outcome, death or home discharge, was not associated with any MRI patterns.
- 5 October 2024
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 45 (5) , 383-394
Imaging of Vertigo and Dizziness: A Site-based Approach Part 3 (Brainstem, Cerebellum, and Miscellaneous)
- 5 October 2024
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 45 (5) , 383-394
Imaging of Vertigo and Dizziness: A Site-based Approach Part 3 (Brainstem, Cerebellum, and Miscellaneous)
- 5 October 2024
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 45 (5) , 353-359
Anatomy and Embryology of the Middle Ear, Labyrinth, and Intracranial Vestibular Pathways
- 5 October 2024
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 45 (5) , 353-359
Anatomy and Embryology of the Middle Ear, Labyrinth, and Intracranial Vestibular Pathways
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S12)
Multiple pathologies underlying a very late‐onset schizophrenia‐like psychosis
Background: Very late‐onset schizophrenia‐like psychosis term was recently introduced and includes schizophrenia, delusional disorders, and paranoid psychosis after 60 years. More than 60% of cases are due to secondary causes, mostly neurodegenerative diseases. We described clinical, neuropathological, and radiological findings of a woman with psychotic symptoms preceding cognitive impairment.Method: Clinical data were obtained by interview with a next of kin. Both hemispheres were fixed in 4% buffered paraformaldehyde within 15 hours of death. The following samples from both fixed hemispheres were embedded in paraffin: middle and inferior frontal, middle and superior temporal, superior frontal and anterior cingulate gyri, angular gyrus, insula, visual cortex, hippocampal formation at the level of the lateral geniculate body, amygdala, basal ganglia at the level of the anterior commissure, thalamus, midbrain, brainstem, and cerebellar cortex and dentate nucleus. All areas were stained with hematoxylin and eosin (H&E), and immunohistochemistry with antibodies against β‐amyloid (4G8), phospho‐tau (AT8), phospho α‐synuclein (81A), phospho TDP‐43, and p62.Result: A 69‐year‐old woman started with visual and auditory hallucinations and delusions, followed by cognitive impairment and hyperorality. Three years later, she became bedridden and died at 73. Postmortem 7T MRI showed diffuse cortical atrophy more prominent in the temporal cortex and anterior hippocampus. Unfixed brain 887g weight. Macroscopy depicted cortical brain atrophy with enlargement of the lateral ventricles, depigmentation moderate of substantia nigra, and severe of locus coeruleus. Microscopy showed bilateral hippocampal sclerosis. At immunohistochemistry: diffuse Lewy‐type pathology corresponding to Braak stage 6 of PD‐related pathology, Braak staging VI for AD, amyloid deposits in diffuse, cored, and perivascular plaques in cortical and subcortical areas (CERAD B and Thal 5), and neuronal, glial TDP‐43 inclusions were found in cortical and limbic areas corresponding to LATE 3 and Staging 6.Conclusion: Late‐onset psychosis is associated with frontotemporal involvement and is frequently observed in those with C9orf72 mutation. Co‐pathologies may influence clinical and neuropsychiatric presentation and disease progression in mixed dementias.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S12)
Open AccessMultiple pathologies underlying a very late‐onset schizophrenia‐like psychosis
Background: Very late‐onset schizophrenia‐like psychosis term was recently introduced and includes schizophrenia, delusional disorders, and paranoid psychosis after 60 years. More than 60% of cases are due to secondary causes, mostly neurodegenerative diseases. We described clinical, neuropathological, and radiological findings of a woman with psychotic symptoms preceding cognitive impairment.Method: Clinical data were obtained by interview with a next of kin. Both hemispheres were fixed in 4% buffered paraformaldehyde within 15 hours of death. The following samples from both fixed hemispheres were embedded in paraffin: middle and inferior frontal, middle and superior temporal, superior frontal and anterior cingulate gyri, angular gyrus, insula, visual cortex, hippocampal formation at the level of the lateral geniculate body, amygdala, basal ganglia at the level of the anterior commissure, thalamus, midbrain, brainstem, and cerebellar cortex and dentate nucleus. All areas were stained with hematoxylin and eosin (H&E), and immunohistochemistry with antibodies against β‐amyloid (4G8), phospho‐tau (AT8), phospho α‐synuclein (81A), phospho TDP‐43, and p62.Result: A 69‐year‐old woman started with visual and auditory hallucinations and delusions, followed by cognitive impairment and hyperorality. Three years later, she became bedridden and died at 73. Postmortem 7T MRI showed diffuse cortical atrophy more prominent in the temporal cortex and anterior hippocampus. Unfixed brain 887g weight. Macroscopy depicted cortical brain atrophy with enlargement of the lateral ventricles, depigmentation moderate of substantia nigra, and severe of locus coeruleus. Microscopy showed bilateral hippocampal sclerosis. At immunohistochemistry: diffuse Lewy‐type pathology corresponding to Braak stage 6 of PD‐related pathology, Braak staging VI for AD, amyloid deposits in diffuse, cored, and perivascular plaques in cortical and subcortical areas (CERAD B and Thal 5), and neuronal, glial TDP‐43 inclusions were found in cortical and limbic areas corresponding to LATE 3 and Staging 6.Conclusion: Late‐onset psychosis is associated with frontotemporal involvement and is frequently observed in those with C9orf72 mutation. Co‐pathologies may influence clinical and neuropsychiatric presentation and disease progression in mixed dementias.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S13)
Bearded capuchin monkey as a model for Alzheimer’s disease (AD) research
Background: The absence of a natural animal model is one of the main challenges to research in AD. AD‐type pathology has been described in chimpanzees and other primates’ brains. The bearded capuchin monkey (Sapajus libidinosus) is a New World primate that attracted attention mainly due to its skill in creating and using tools. We evaluated the brains of three captive capuchins (9, 29 and 33 years‐old) who died from natural causes at the Primate Center of University of Brasilia.Method: Whole brain was fixed in 4% buffered paraformaldehyde within 12 hours of death for three weeks. Structural 7T MRI was acquired in one case before brain slicing. Consecutive coronal sections from the fixed brain were embedded in paraffin, and 5um sections from paraffin blocks were used for staining and immunohistochemistry evaluation. All brain sections were stained with hematoxylin and eosin. Immunohistochemistry with β‐amyloid (4G8), phosphorylated tau (AT8), p62, TDP‐43, α‐synuclein (81A), 68 kDa neurofilament (2F11), GFAP and CD68 antibodies were performed in selected sections to analyze the following areas: frontal cortex, temporal cortex, parietal cortex, occipital cortex, anterior cingulate cortex, hippocampus, amygdala, basal ganglia, thalamus, mesencephalon, pons, medulla oblongata, and cerebellum.Result: Macroscopic evaluation of the brains showed considerable cortical gyrification. In addition, thick cortical ribbon was observed in the MRI. A complete neuropathological evaluation was available for two cases. Widespread β‐amyloid immunoreactivity was observed in the form of diffuse deposits, core‐space‐corona plaques, perivascular plaques, and amyloid angiopathy. A high frequency of classic neuritic plaques was observed. P‐tau antibody failed to label the dystrophic neurites. However, these lesions were revealed with p62 and neurofilament antibodies. Astrocyte hypertrophy surrounding plaques was observed without microglial activation. Very few hyperphosphorylated tau aggregates resembling neurofibrillary tangles and neuropil threads were found in the temporal and frontal cortex, and Lewy‐type and TDP‐43 pathology were not observed.Conclusion: In summary, we found β‐amyloid immunoreactivity, classic neuritic plaques surrounded by astrocyte hypertrophy, but only rare P‐tau aggregates. To our knowledge, this is the first evidence reporting brain AD‐like alterations in capuchin monkeys which suggest that this species can be considered an advantageous animal model for AD research.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S13)
Open AccessBearded capuchin monkey as a model for Alzheimer’s disease (AD) research
Background: The absence of a natural animal model is one of the main challenges to research in AD. AD‐type pathology has been described in chimpanzees and other primates’ brains. The bearded capuchin monkey (Sapajus libidinosus) is a New World primate that attracted attention mainly due to its skill in creating and using tools. We evaluated the brains of three captive capuchins (9, 29 and 33 years‐old) who died from natural causes at the Primate Center of University of Brasilia.Method: Whole brain was fixed in 4% buffered paraformaldehyde within 12 hours of death for three weeks. Structural 7T MRI was acquired in one case before brain slicing. Consecutive coronal sections from the fixed brain were embedded in paraffin, and 5um sections from paraffin blocks were used for staining and immunohistochemistry evaluation. All brain sections were stained with hematoxylin and eosin. Immunohistochemistry with β‐amyloid (4G8), phosphorylated tau (AT8), p62, TDP‐43, α‐synuclein (81A), 68 kDa neurofilament (2F11), GFAP and CD68 antibodies were performed in selected sections to analyze the following areas: frontal cortex, temporal cortex, parietal cortex, occipital cortex, anterior cingulate cortex, hippocampus, amygdala, basal ganglia, thalamus, mesencephalon, pons, medulla oblongata, and cerebellum.Result: Macroscopic evaluation of the brains showed considerable cortical gyrification. In addition, thick cortical ribbon was observed in the MRI. A complete neuropathological evaluation was available for two cases. Widespread β‐amyloid immunoreactivity was observed in the form of diffuse deposits, core‐space‐corona plaques, perivascular plaques, and amyloid angiopathy. A high frequency of classic neuritic plaques was observed. P‐tau antibody failed to label the dystrophic neurites. However, these lesions were revealed with p62 and neurofilament antibodies. Astrocyte hypertrophy surrounding plaques was observed without microglial activation. Very few hyperphosphorylated tau aggregates resembling neurofibrillary tangles and neuropil threads were found in the temporal and frontal cortex, and Lewy‐type and TDP‐43 pathology were not observed.Conclusion: In summary, we found β‐amyloid immunoreactivity, classic neuritic plaques surrounded by astrocyte hypertrophy, but only rare P‐tau aggregates. To our knowledge, this is the first evidence reporting brain AD‐like alterations in capuchin monkeys which suggest that this species can be considered an advantageous animal model for AD research.
- Open Access
- 15 January 2022
- Published by Springer Nature in Insights into Imaging
- Vol. 13 (1) , 1-12
Postmortem brain 7T MRI with minimally invasive pathological correlation in deceased COVID-19 subjects
Background: Brain abnormalities are a concern in COVID-19, so we used minimally invasive autopsy (MIA) to investigate it, consisting of brain 7T MR and CT images and tissue sampling via transethmoidal route with at least three fragments: the first one for reverse transcription polymerase chain reaction (RT-PCR) analysis and the remaining fixed and stained with hematoxylin and eosin. Two mouse monoclonal anti-coronavirus (SARS-CoV-2) antibodies were employed in immunohistochemical (IHC) reactions. Results: Seven deceased COVID-19 patients underwent MIA with brain MR and CT images, six of them with tissue sampling. Imaging findings included infarcts, punctate brain hemorrhagic foci, subarachnoid hemorrhage and signal abnormalities in the splenium, basal ganglia, white matter, hippocampi and posterior cortico-subcortical. Punctate brain hemorrhage was the most common finding (three out of seven cases). Brain histological analysis revealed reactive gliosis, congestion, cortical neuron eosinophilic degeneration and axonal disruption in all six cases. Other findings included edema (5 cases), discrete perivascular hemorrhages (5), cerebral small vessel disease (3), perivascular hemosiderin deposits (3), Alzheimer type II glia (3), abundant corpora amylacea (3), ischemic foci (1), periventricular encephalitis foci (1), periventricular vascular ectasia (1) and fibrin thrombi (1). SARS-CoV-2 RNA was detected with RT-PCR in 5 out of 5 and IHC in 6 out 6 patients (100%). Conclusions: Despite limited sampling, MIA was an effective tool to evaluate underlying pathological brain changes in deceased COVID-19 patients. Imaging findings were varied, and pathological features corroborated signs of hypoxia, alterations related to systemic critically ill and SARS-CoV-2 brain invasion.
- 15 January 2022
- Published by Springer Nature in Insights into Imaging
- Vol. 13 (1) , 1-12
Open AccessPostmortem brain 7T MRI with minimally invasive pathological correlation in deceased COVID-19 subjects
Background: Brain abnormalities are a concern in COVID-19, so we used minimally invasive autopsy (MIA) to investigate it, consisting of brain 7T MR and CT images and tissue sampling via transethmoidal route with at least three fragments: the first one for reverse transcription polymerase chain reaction (RT-PCR) analysis and the remaining fixed and stained with hematoxylin and eosin. Two mouse monoclonal anti-coronavirus (SARS-CoV-2) antibodies were employed in immunohistochemical (IHC) reactions. Results: Seven deceased COVID-19 patients underwent MIA with brain MR and CT images, six of them with tissue sampling. Imaging findings included infarcts, punctate brain hemorrhagic foci, subarachnoid hemorrhage and signal abnormalities in the splenium, basal ganglia, white matter, hippocampi and posterior cortico-subcortical. Punctate brain hemorrhage was the most common finding (three out of seven cases). Brain histological analysis revealed reactive gliosis, congestion, cortical neuron eosinophilic degeneration and axonal disruption in all six cases. Other findings included edema (5 cases), discrete perivascular hemorrhages (5), cerebral small vessel disease (3), perivascular hemosiderin deposits (3), Alzheimer type II glia (3), abundant corpora amylacea (3), ischemic foci (1), periventricular encephalitis foci (1), periventricular vascular ectasia (1) and fibrin thrombi (1). SARS-CoV-2 RNA was detected with RT-PCR in 5 out of 5 and IHC in 6 out 6 patients (100%). Conclusions: Despite limited sampling, MIA was an effective tool to evaluate underlying pathological brain changes in deceased COVID-19 patients. Imaging findings were varied, and pathological features corroborated signs of hypoxia, alterations related to systemic critically ill and SARS-CoV-2 brain invasion.
- 7 January 2021
- Published by Springer Nature in Neurological Sciences
- Vol. 42 (2) , 479-489
Clinical, cerebrospinal fluid, and neuroimaging findings in COVID-19 encephalopathy: a case series
Objective To describe the clinical, neurological, neuroimaging, and cerebrospinal fluid (CSF) findings associated with encephalopathy in patients admitted to a COVID-19 tertiary reference center. Methods We retrospectively reviewed records of consecutive patients with COVID-19 evaluated by a consulting neurology team from March 30, 2020 through May 15, 2020. Results Fifty-five patients with confirmed SARS-CoV-2 were included, 43 of whom showed encephalopathy, and were further divided into mild, moderate, and severe encephalopathy groups. Nineteen patients (44%) had undergone mechanical ventilation and received intravenous sedatives. Eleven (26%) patients were on dialysis. Laboratory markers of COVID-19 severity were very common in encephalopathy patients, but did not correlate with the severity of encephalopathy. Thirty-nine patients underwent neuroimaging studies, which showed mostly non-specific changes. One patient showed lesions possibly related to CNS demyelination. Four had suffered an acute stroke. SARS-CoV-2 was detected by RT-PCR in only one of 21 CSF samples. Two CSF samples showed elevated white blood cell count and all were negative for oligoclonal bands. In our case series, the severity of encephalopathy correlated with higher probability of death during hospitalization (OR = 5.5 for each increment in the degree of encephalopathy, from absent (0) to mild (1), moderate (2), or severe (3), p < 0.001). Conclusion In our consecutive series with 43 encephalopathy cases, neuroimaging and CSF analysis did not support the role of direct viral CNS invasion or CNS inflammation as the cause of encephalopathy.
- 7 January 2021
- Published by Springer Nature in Neurological Sciences
- Vol. 42 (2) , 479-489
Clinical, cerebrospinal fluid, and neuroimaging findings in COVID-19 encephalopathy: a case series
Objective To describe the clinical, neurological, neuroimaging, and cerebrospinal fluid (CSF) findings associated with encephalopathy in patients admitted to a COVID-19 tertiary reference center. Methods We retrospectively reviewed records of consecutive patients with COVID-19 evaluated by a consulting neurology team from March 30, 2020 through May 15, 2020. Results Fifty-five patients with confirmed SARS-CoV-2 were included, 43 of whom showed encephalopathy, and were further divided into mild, moderate, and severe encephalopathy groups. Nineteen patients (44%) had undergone mechanical ventilation and received intravenous sedatives. Eleven (26%) patients were on dialysis. Laboratory markers of COVID-19 severity were very common in encephalopathy patients, but did not correlate with the severity of encephalopathy. Thirty-nine patients underwent neuroimaging studies, which showed mostly non-specific changes. One patient showed lesions possibly related to CNS demyelination. Four had suffered an acute stroke. SARS-CoV-2 was detected by RT-PCR in only one of 21 CSF samples. Two CSF samples showed elevated white blood cell count and all were negative for oligoclonal bands. In our case series, the severity of encephalopathy correlated with higher probability of death during hospitalization (OR = 5.5 for each increment in the degree of encephalopathy, from absent (0) to mild (1), moderate (2), or severe (3), p < 0.001). Conclusion In our consecutive series with 43 encephalopathy cases, neuroimaging and CSF analysis did not support the role of direct viral CNS invasion or CNS inflammation as the cause of encephalopathy.
- Open Access
- 1 December 2020
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 78 (12) , 805-810
Acute Disseminated Encephalomyelitis in COVID-19: presentation of two cases and review of the literature
Background: Neurological manifestations of COVID-19 are still incompletely understood. Neurological manifestations may be due to direct viral effect on neurons and glial cells, to an immune-mediated response to the virus, or to a hypercoagulable state and associated endothelial damage, as well as to severe systemic disease with prolonged intensive care unit stay. Objective: To describe two patients with severe SARS-CoV-2 infection and delayed recovery of consciousness after sedation withdrawal, in whom MRI disclosed multifocal white matter brain lesions, compatible with the diagnosis of acute disseminated encephalomyelitis. Methods: Observational report of two cases of severe COVID-19 infection in patients from two tertiary hospitals in São Paulo, Brazil. Results: These patients underwent neurologic and systemic evaluation for delayed awakening after sedation withdrawal. MRI displayed multifocal centrum semiovale lesions, suggestive of demyelinating inflammation. Cerebrospinal fluid (CSF) polymerase chain reaction (PCR) for SARS-CoV-2 was negative in both cases. Conclusion: A recurrent pattern of multifocal white matter lesions can occur in COVID-19 patients, possibly associated with delayed awakening. Additional studies are necessary to elucidate the role of the viral infection and of inflammatory and immune-mediated associated changes in neurological manifestations of COVID-19.
- 1 December 2020
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 78 (12) , 805-810
Open AccessAcute Disseminated Encephalomyelitis in COVID-19: presentation of two cases and review of the literature
Background: Neurological manifestations of COVID-19 are still incompletely understood. Neurological manifestations may be due to direct viral effect on neurons and glial cells, to an immune-mediated response to the virus, or to a hypercoagulable state and associated endothelial damage, as well as to severe systemic disease with prolonged intensive care unit stay. Objective: To describe two patients with severe SARS-CoV-2 infection and delayed recovery of consciousness after sedation withdrawal, in whom MRI disclosed multifocal white matter brain lesions, compatible with the diagnosis of acute disseminated encephalomyelitis. Methods: Observational report of two cases of severe COVID-19 infection in patients from two tertiary hospitals in São Paulo, Brazil. Results: These patients underwent neurologic and systemic evaluation for delayed awakening after sedation withdrawal. MRI displayed multifocal centrum semiovale lesions, suggestive of demyelinating inflammation. Cerebrospinal fluid (CSF) polymerase chain reaction (PCR) for SARS-CoV-2 was negative in both cases. Conclusion: A recurrent pattern of multifocal white matter lesions can occur in COVID-19 patients, possibly associated with delayed awakening. Additional studies are necessary to elucidate the role of the viral infection and of inflammatory and immune-mediated associated changes in neurological manifestations of COVID-19.
- Open Access
Clinical, cerebrospinal fluid and neuroimaging findings in COVID-19 encephalopathy: a case series
Objective: To describe the clinical, neurological, neuroimaging and cerebrospinal fluid (CSF) findings associated with encephalopathy in patients admitted to a COVID-19 tertiary reference center. Methods: We retrospectively reviewed records of consecutive patients with COVID-19 evaluated by a consulting neurology team from March 30, 2020 through May 15, 2020. Results: Fifty-five patients with confirmed SARS-CoV-2 were included, 43 of whom showed encephalopathy, and were further divided into mild, moderate and severe encephalopathy groups. Nineteen patients (44%) had undergone mechanical ventilation and received intravenous sedatives. Eleven (26%) patients were on dialysis. Laboratory markers of COVID-19 severity were very common in encephalopathy patients, but did not correlate with the severity of encephalopathy. Thirty-nine patients underwent neuroimaging studies, which showed mostly non-specific changes. One patient showed lesions possibly related to CNS demyelination. Four had suffered an acute stroke. SARS-CoV-2 was detected by RT-PCR in only one of 21 CSF samples. Two CSF samples showed elevated white blood cell count and all were negative for oligoclonal bands. In our case series the severity of encephalopathy correlated with higher probability of death during hospitalization (OR = 5.5 for each increment in the degree of encephalopathy, from absent (0) to mild (1), moderate (2) or severe (3), p<0.001). Conclusion: In our consecutive series with 43 encephalopathy cases, neuroimaging and CSF analysis did not support the role of direct viral CNS invasion or CNS inflammation as the cause of encephalopathy.
Open AccessClinical, cerebrospinal fluid and neuroimaging findings in COVID-19 encephalopathy: a case series
Objective: To describe the clinical, neurological, neuroimaging and cerebrospinal fluid (CSF) findings associated with encephalopathy in patients admitted to a COVID-19 tertiary reference center. Methods: We retrospectively reviewed records of consecutive patients with COVID-19 evaluated by a consulting neurology team from March 30, 2020 through May 15, 2020. Results: Fifty-five patients with confirmed SARS-CoV-2 were included, 43 of whom showed encephalopathy, and were further divided into mild, moderate and severe encephalopathy groups. Nineteen patients (44%) had undergone mechanical ventilation and received intravenous sedatives. Eleven (26%) patients were on dialysis. Laboratory markers of COVID-19 severity were very common in encephalopathy patients, but did not correlate with the severity of encephalopathy. Thirty-nine patients underwent neuroimaging studies, which showed mostly non-specific changes. One patient showed lesions possibly related to CNS demyelination. Four had suffered an acute stroke. SARS-CoV-2 was detected by RT-PCR in only one of 21 CSF samples. Two CSF samples showed elevated white blood cell count and all were negative for oligoclonal bands. In our case series the severity of encephalopathy correlated with higher probability of death during hospitalization (OR = 5.5 for each increment in the degree of encephalopathy, from absent (0) to mild (1), moderate (2) or severe (3), p<0.001). Conclusion: In our consecutive series with 43 encephalopathy cases, neuroimaging and CSF analysis did not support the role of direct viral CNS invasion or CNS inflammation as the cause of encephalopathy.